Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy: study protocol

Autor: Terho Lehtimäki, Antti Rannikko, Mikkel Fode, Michael Borre, Teuvo Tammela, Aino Siltari, Peter Østergren, Mika Helminen, Timo Marttila, Otto Ettala, Heikki Seikkula, Peter Boström, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Andres Kotsar, Paavo V Raittinen, Arto Salonen, Hanna Ronkainen, Sven Löffeler, Teemu J Murtola

Publikováno v: BMJ Open, Vol 12, Iss 4 (2022)

Introduction Blood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of statins has been associated with prolonged time

Externí odkaz: https://doaj.org/article/e505fd6f8e7d4cd2a0760857e0947b59

MP80-15 3D LAPAROSCOPIC VERSUS ROBOT ASSISTED LAPAROSCOPIC PROSTATECTOMY: 1-YEAR FUNCTIONAL RESULTS OF a RANDOMIZED PROSPECTIVE STUDY

Autor: Henry Haapiainen, Teemu Murtola, Juha Koskimäki, Jarno Riikonen, Tomi Pakarainen, Mika Raitanen, Antti Kaipia

Publikováno v: Journal of Urology. 209

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5887e6ef01a8706731e18778a31915fa
https://doi.org/10.1097/ju.0000000000003357.15

Appendix Table 1. from The Number of Screening Cycles Needed to Reduce Prostate Cancer Mortality in the Finnish Section of the European Randomized Study of Prostate Cancer (ERSPC)

Autor: Anssi Auvinen, Teuvo L.J. Tammela, Ulf-Håkan Stenman, Paula Kujala, Jani Raitanen, Kimmo Taari, Kirsi Talala, Jaakko Nevalainen, Tomi Pakarainen

Results of the case-control study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b826f0c53f4f5851eb6ba25e810d4da7
https://doi.org/10.1158/1078-0432.22474362.v1

Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy : study protocol

Autor: Aino Siltari, Jarno Riikonen, Juha Koskimäki, Tomi Pakarainen, Otto Ettala, Peter Boström, Heikki Seikkula, Andres Kotsar, Teuvo Tammela, Mika Helminen, Paavo V Raittinen, Terho Lehtimäki, Mikkel Fode, Peter Østergren, Michael Borre, Antti Rannikko, Timo Marttila, Arto Salonen, Hanna Ronkainen, Sven Löffeler, Teemu J Murtola

Publikováno v: Siltari, A, Riikonen, J, Koskimäki, J, Pakarainen, T, Ettala, O, Boström, P, Seikkula, H, Kotsar, A, Tammela, T, Helminen, M, Raittinen, P V, Lehtimäki, T, Fode, M, Østergren, P, Borre, M, Rannikko, A, Marttila, T, Salonen, A, Ronkainen, H, Löffeler, S & Murtola, T J 2022, ' Randomised double-blind phase 3 clinical study testing impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy : study protocol ', BMJ Open, vol. 12, no. 4, e050264 . https://doi.org/10.1136/bmjopen-2021-050264

IntroductionBlood cholesterol is likely a risk factor for prostate cancer prognosis and use of statins is associated with lowered risk of prostate cancer recurrence and progression. Furthermore, use of statins has been associated with prolonged time

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4944b012a4cd842994136075a1e269c
http://hdl.handle.net/10138/344338

Men's experiences of the impact of penile cancer surgery on their lives: A qualitative study

Autor: Minna Törnävä, Eeva Harju, Hanna Vasarainen, Tomi Pakarainen, Ilkka Perttilä, Antti Kaipia

Publikováno v: European Journal of Cancer Care. 31

Surgery is the primary treatment for invasive penile cancer (PC). Postoperative changes in genital anatomy and function may lead to altered body and self-image, compromised sexual function and subsequent psychological problems. The aim of this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d0ee578a37163ec69c5cf92d579e66
https://doi.org/10.1111/ecc.13548